Tevogen TVGN Institutional Ownership

Updated Oct 9, 2026

Tevogen Inc. (NASDAQ:TVGN) was reported as a holding by 32 institutional investors in 13F filings for the quarter ended June 30, 2026.

• Collectively, these holders controlled 2.82% of Tevogen's outstanding shares in Q2 2026, down from 3.90% in Q1 2026.
• Total holdings of Tevogen shares fell 20.43% from Q1 2026, and the number of holders fell 38.46% from Q2 2025.
• Of the 32 holders, 21 added to their positions, 8 reduced their stakes and 3 left their positions unchanged in Q2 2026.
• In total, institutional investors held 108.07K shares of Tevogen at the end of Q2 2026, down 27.75K from the prior quarter and up 14.35K from a year earlier.
• Vanguard Capital Management LLC held the largest position in TVGN at 23.98K shares as of June 30, 2026, or 0.63% of shares outstanding.
• Holders that added the most shares of Tevogen in Q2 2026 were Morgan Stanley (+1.48K shares), Russell Investments Group, Ltd. (+726 shares), GAMMA Investing LLC (+622 shares), Tower Research Capital LLC (+553 shares) and Royal Bank of Canada (+33 shares).
• Holders that trimmed the most shares of Tevogen in Q2 2026 while keeping a position were Vanguard Capital Management LLC (-9.27K shares), UBS Group AG (-2.48K shares), Vanguard Fiduciary Trust Co (-530 shares), FMR LLC (-331 shares) and Wells Fargo & Company (-297 shares).
• Business Quant data shows the 10 biggest positions in Tevogen as of Q2 2026 were held by Vanguard Capital Management LLC (23.98K shares), Morgan Stanley (18.81K shares), AQR Capital Management LLC (17.24K shares), Goldman Sachs Group Inc (14.16K shares), Jane Street Group, LLC (11.18K shares), FMR LLC (9.83K shares), Russell Investments Group, Ltd. (6.53K shares), Tower Research Capital LLC (1.49K shares), UBS Group AG (1.08K shares) and Vanguard Fiduciary Trust Co (838 shares).